A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project

Dermatol Reports. 2022 Sep 26;14(3):9541. doi: 10.4081/dr.2022.9541. eCollection 2022 Sep 14.

Abstract

Psoriasis is a complex disease often needing a multidisciplinary approach. In particular, the collaboration between dermatologist and rheumatologist is crucial for the management of patients suffering from both psoriasis (PSO) and psoriatic arthritis (PsA). Here we report a series of recommendations from a group of experts, as a result of a Consensus Conference, defining the circumstances in which it is preferable or even mandatory, depending on the available settings, to rely on the opinion of the two specialists, jointly or in a deferred manner. Indications are given on how to organize a 3rd level joint Dermatology- Rheumatology care unit, in connection with 1st and 2nd level clinicians of both specialties, GPs, and other specialists involved in the management of psoriasis. A potential patient journey is suggested, that can be used as a basis for future design and validation of national and/or local diagnostic therapeutic and assistance pathways.

Keywords: Consensus Conference; Dermatology; Patient management; Psoriasis; Psoriatic Arthritis; Rheumatology.

Grants and funding

Funding: The Consensus Conference was arranged with an unrestricted educational grant provided by Amgen, Janssen, Lilly, Novartis.